Gildan Activewear Reports on Shareholders’ Voting Results
May 29, 2024 07:00 ET
|
Gildan Activewear, Inc.
MONTRÉAL, May 29, 2024 (GLOBE NEWSWIRE) -- Gildan Activewear Inc. (GIL: TSX and NYSE) (“Gildan” or the “Company”) today announced that the eight director nominees, being all of the existing...
Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
May 29, 2024 07:00 ET
|
Omega Therapeutics
CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable...
Akero Therapeutics to Present at the Jefferies Global Healthcare Conference
May 29, 2024 07:00 ET
|
Akero Therapeutics Inc.
SOUTH SAN FRANCISCO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious...
Global Plant Phenotyping Market Size To Worth USD 790.5 Million By 2033 | CAGR Of 11.69%
May 29, 2024 07:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , May 29, 2024 (GLOBE NEWSWIRE) -- The Global Plant Phenotyping Market Size is to Grow from USD 261.7 Million in 2023 to USD 790.5 Million by 2033, at a Compound Annual...
The Habit Burger Grill Opens New Drive-Thru in Fresno, Its Fifth Location in the California City
May 29, 2024 07:00 ET
|
The Habit Burger Grill
IRVINE, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- The Habit Burger Grill, the California-based restaurant company renowned for its award-winning Charburgers grilled over an open flame, signature...
Host Hotels & Resorts Enters into Agreement to Acquire Turtle Bay Resort in Hawaii
May 29, 2024 07:00 ET
|
Host Hotels & Resorts, L.P.
BETHESDA, Md., May 29, 2024 (GLOBE NEWSWIRE) -- Host Hotels & Resorts, Inc. (NASDAQ: HST) (“Host” or the “Company”), the nation’s largest lodging real estate investment trust, today announced...
Kynexis Appoints Esteemed Scientific Advisory Board Members to Advance Precision Therapeutics for Brain Diseases
May 29, 2024 07:00 ET
|
Kynexis
NAARDEN, The Netherlands, May 29, 2024 (GLOBE NEWSWIRE) -- Kynexis, a clinical-stage biotechnology company focused on precision therapeutics by leveraging biomarkers and human genetics for brain...
Athira Pharma to Participate in Upcoming June Conferences
May 29, 2024 07:00 ET
|
Athira Pharma, Inc.
BOTHELL, Wash., May 29, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health...
Kymera Therapeutics to Participate in Upcoming June Investor Conferences
May 29, 2024 07:00 ET
|
Kymera Therapeutics, Inc.
WATERTOWN, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using...
Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma
May 29, 2024 07:00 ET
|
Immunocore Holdings plc
Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma Following recent consultation with FDA,...